Rambeck W A, Weiser H, Meier W, Zucker H
Institute for Physiology, Veterinary Faculty, Ludwig-Maximilian University of Munich, FRG.
Ann Nutr Metab. 1988;32(2):108-11. doi: 10.1159/000177415.
The vitamin D3 metabolites 1 alpha,24R,25- and 1 alpha,25S,26-trihydroxy vitamin D3 and their combinations with 1 alpha,25-dihydroxy vitamin D3 were tested for antirachitic activity in rats, chicken and Japanese quails. The trihydroxylated compounds were found to increase the activity of 1 alpha,25-dihydroxy vitamin D3. Since this synergistic effect is restricted to calcium absorption and bone formation while bone calcium mobilization is unchanged, the combined administration might improve calcium balance. These findings raise the possibility of a more efficient therapy of vitamin D-dependent diseases with limited amounts of 1 alpha,25-dihydroxy vitamin D3.
对维生素D3代谢物1α,24R,25 - 三羟基维生素D3和1α,25S,26 - 三羟基维生素D3及其与1α,25 - 二羟基维生素D3的组合在大鼠、鸡和日本鹌鹑中进行了抗佝偻病活性测试。发现三羟基化化合物可增强1α,25 - 二羟基维生素D3的活性。由于这种协同作用仅限于钙吸收和骨形成,而骨钙动员不变,联合给药可能会改善钙平衡。这些发现增加了用有限量的1α,25 - 二羟基维生素D3更有效地治疗维生素D依赖性疾病的可能性。